新型コロナウイルス感染症 (COVID-19) が蔓延しておりますが、我々Selleckは従業員とビジネスパートナーの安全を保つための複数の対策を実施し、お客様に製品を継続してお届けします。 COVID-19関連製品はこちら

ホームページ
COVID-19
阻害剤
- 研究分野別
- PI3K/Akt/mTOR
  - PI3K
  - mTOR
  - Akt
  - GSK-3
  - ATM/ATR
  - PDK
  - AMPK
  - DNA-PK
  - PTEN
  - MELK
  - PP2A
- Epigenetics
  - HDAC
  - AMPK
  - PARP
  - JAK
  - Pim
  - HIF
  - PKC
  - Aurora Kinase
  - Sirtuin
  - Histone Demethylase
  - Epigenetic Reader Domain
- Methylation
  - DNA Methyltransferase
  - NSD3
  - SAM MTase
  - WDR5
  - DOT1
  - SETD
  - MLL
  - PRMT
  - LSD1
  - COMT
  - FTO
- Immunology & Inflammation
  - CD markers
  - PD-1/PD-L1
  - COX
  - CCR
  - Histamine Receptor
  - IL Receptor
  - CXCR
  - NOD
  - ROS
  - gp120/CD4
  - Nrf2
- Protein Tyrosine Kinase
  - VEGFR
  - MEK
  - EGFR
  - PDGFR
  - c-Met
  - HER2
  - IGF-1R
  - FLT3
  - FGFR
  - Bcr-Abl
  - c-Kit
- Angiogenesis
  - VEGFR
  - JAK
  - EGFR
  - PDGFR
  - HER2
  - FLT3
  - FGFR
  - HIF
  - VDA
  - Bcr-Abl
  - Src
- Apoptosis
  - PD-1/PD-L1
  - Bcl-2
  - Caspase
  - p53
  - TNF-alpha
  - Mdm2
  - Survivin
  - Ras
  - c-RET
  - PERK
  - IAP
- Autophagy
  - Autophagy
  - Nrf2
  - LRRK2
  - CXCR
  - LC3
  - Mitophagy
  - OGA
  - cGAS
  - FKBP
  - ULK
  - Heme Oxygenase
- ER stress & UPR
  - JNK
  - HSP (HSP90)
  - PERK
  - ASK
  - IRE1
  - PKR
  - eIF
  - PDI
- JAK/STAT
  - JAK
  - STAT
  - EGFR
  - Pim
- MAPK
  - S6 Kinase
  - MEK
  - Raf
  - p38 MAPK
  - JNK
  - Ras
  - ERK
  - TAK1
  - TOPK
  - ASK
  - KLF
- Cytoskeletal Signaling
  - Akt
  - Bcr-Abl
  - Wnt/beta-catenin
  - PKC
  - FAK
  - HSP (HSP90)
  - Kinesin
  - ROCK
  - Microtubule Associated
  - Integrin
  - Dynamin
- Cell Cycle
  - CDK
  - DNA/RNA Synthesis
  - PD-1/PD-L1
  - Ras
  - Aurora Kinase
  - HSP (HSP90)
  - Kinesin
  - Chk
  - ROCK
  - Microtubule Associated
  - DHFR
- TGF-beta/Smad
  - TGF-beta/Smad
  - Bcr-Abl
  - PKC
  - ROCK
化合物ライブラリー
InVivo抗体
治療用抗体
新製品
お問い合わせ

治療用抗体

Atezolizumab (anti-PD-L1)

Isotype: Human IgG1
Relatlimab (anti-LAG-3)

Isotype: Human IgG4, κ
Tremelimumab (anti-CTLA-4)

Isotype: Human IgG2
Cetuximab (anti-EGFR)

Isotype: Human IgG1
Nivolumab (anti-PD-1)

Isotype: Human IgG4
Pembrolizumab (anti-PD-1)

Isotype: Human IgG4
Trastuzumab (anti-HER2)

Isotype: Human IgG1
Rituximab (anti-CD20)

Isotype: Human IgG1
Pertuzumab (anti-HER2)

Isotype: Human IgG1
Bevacizumab (anti-VEGF)

Isotype: Human IgG1
Ipilimumab (anti-CTLA-4)

Isotype: Human IgG1
Tocilizumab (anti-IL-6R)

Isotype: Human IgG1
Durvalumab (anti-PD-L1)

Isotype: Human IgG1
Avelumab (anti-PD-L1)

Isotype: Human IgG1
Daratumumab (anti-CD38)

Isotype: Human IgG1
Adalimumab (anti-TNF-alpha)

Isotype: Human IgG1
Infliximab (anti-TNF-alpha)

Isotype: Chimeric IgG1
Obinutuzumab (anti-CD20)

Isotype: Humanized IgG1
Ustekinumab (anti-IL-12/IL-23)

Isotype: Human IgG1
Secukinumab (anti-IL-17A)

Isotype: Human IgG1
Ramucirumab (anti-VEGFR2)

Isotype: human IgG1
Camrelizumab (anti-PD-1)

Isotype: Human IgG4
Sarilumab (anti-IL-6Rα)

Isotype: Human IgG1
Spartalizumab (anti-PD-1)

Isotype: Human IgG4
Denosumab (anti-RANK ligand)

Isotype: human IgG4
Cemiplimab (anti-PD-1)

Isotype: Human IgG4